1. Home
  2. Detail

@alizaraheel66:

AlizaRaheel66
AlizaRaheel66
Open In TikTok:
Region: PK
Saturday 12 October 2024 13:53:12 GMT
1198
238
0
2

Music

Download

No Watermark .mp4 (1.19MB) No Watermark(HD) .mp4 (1.19MB) Watermark .mp4 (0MB) Music .mp3

Comments

There are no more comments for this video.
To see more videos from user @alizaraheel66, please go to the Tikwm homepage.

Other Videos

#anfreezemyacount #viraltiktokvideo #foryou #viraltiktokvideo کبھی اونا چترال لواری #anfreezemyacount
#anfreezemyacount #viraltiktokvideo #foryou #viraltiktokvideo کبھی اونا چترال لواری #anfreezemyacount
Jorts win
Jorts win
Going where the wind takes us 🌬️ @solersss @clakovi #MANGOSlowSummer
Going where the wind takes us 🌬️ @solersss @clakovi #MANGOSlowSummer
#TZUYU | T- Z- U- Y- U- TZUYU! @مَوج 💞 | #twicetzuyu #tzuyuedit #tzuyuspellingname #choutzuyu
#TZUYU | T- Z- U- Y- U- TZUYU! @مَوج 💞 | #twicetzuyu #tzuyuedit #tzuyuspellingname #choutzuyu
#factfiles #kadamasaudia🇸🇦 #ugandatiktok #fyp #trending
#factfiles #kadamasaudia🇸🇦 #ugandatiktok #fyp #trending
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information. #Hemlibra #emicizumabkxwh #travel #flying #africa
Expand for Serious Side Effects incl. potential for blood to clot, and see profile for the HEMLIBRA full Prescribing Information and Medication Guide. Intended for US audiences only. ------ What is HEMLIBRA? HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors. ------ What is the most important information I should know about HEMLIBRA? HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC; Feiba®) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots. -- These serious side effects include: • Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small blood vessels that may cause harm to your kidneys, brain, and other organs • Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head -- Carefully follow your healthcare provider’s instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and schedule to use for breakthrough bleed treatment. If aPCC (Feiba®) is needed, talk to your healthcare provider in case you feel you need more than 100 U/kg of aPCC (Feiba®) total. -- Your body may make antibodies against HEMLIBRA, which may stop HEMLIBRA from working properly. Contact your healthcare provider immediately if you notice that HEMLIBRA has stopped working for you (eg, increase in bleeds). -- The most common side effects of HEMLIBRA include: injection site reactions (redness, tenderness, warmth, or itching at the site of injection), headache, and joint pain. These are not all of the possible side effects of HEMLIBRA. You can speak with your healthcare provider for more information. #Hemlibra #emicizumabkxwh #travel #flying #africa

About

Legal